International meeting
Improving Adoptive Cell Therapy
Thu May 30, 2024 at 09:00 AM to Fri May 31, 2024 at 02:00 PM
Timezone : Europe/Paris
Centre de Recherche des Cordeliers, 15 Rue de l'École de Médecine, 75006 Paris
Adoptive cell therapy, particularly CAR T-cell therapy, has marked a revolutionary milestone in the treatment of hematological malignancies and is now making strides in the realm of auto-immune diseases. However, for solid tumors, there remains a substantial path ahead.
This congress will delve into the critical aspects of optimizing adoptive cell therapy. The first segment will explore the host conditions for greater efficacy of adoptive cell therapy. Following this, a dedicated session will focus on T-cell engineering, and lastly, we will examine novel targets for CAR T-cell therapy.
The meeting is designed to provide networking between clinicians, scientists from academic and industrial parterns in the field of cell therapies.
This event will bring together the foremost experts in immunology, oncology, and cellular therapy.
This congress will delve into the critical aspects of optimizing adoptive cell therapy. The first segment will explore the host conditions for greater efficacy of adoptive cell therapy. Following this, a dedicated session will focus on T-cell engineering, and lastly, we will examine novel targets for CAR T-cell therapy.
The meeting is designed to provide networking between clinicians, scientists from academic and industrial parterns in the field of cell therapies.
This event will bring together the foremost experts in immunology, oncology, and cellular therapy.
Deadline for abstract submission: April 2, 2024
Please submit your abstract to the following address:
Improvingact2024@gmail.com
Organizing Comittee
Camille Bigenwald, MD, PhD
Laurie Menger, PhD
Prof. Laurence Zitvogel
Speakers
FAQ
Host conditions
Targeting tumor antigens
T cell engineering
Documents to download
Date and place
Thu May 30, 2024 at 09:00 AM to Fri May 31, 2024 at 02:00 PM
Timezone : Europe/Paris
